Ex vivo characteristic assessment of transcutaneous vaccine device by using human skin samples (age-comparison)

Ex vivo characteristic assessment of transcutaneous vaccine device by using human skin samples (age-comparison) - Ex vivo characteristic assessment of transcutaneous vaccine device by using human skin samples (age-comparison)

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009451

Enrollment

Registered

2012-12-01

Start date

2012-12-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Flu

Interventions

Patients who will be performed skin surgery from December 2012 to March 2014 and who provide approximately 2 square meter surplus skin once age: 5-15y.o. Patients who will be performed skin surgery f

65y.o.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patient who agreed informed consent to provide surplus skin during skin surgery

Exclusion criteria

Exclusion criteria: Patient who disagreed informed consent to provide surplus skin during skin surgery

Design outcomes

Primary

Measure	Time frame
Antigen delivery mechanisms by microneedles will be elucidated in human skin by ex vivo studies.	—

Countries

Japan

Contacts

Public ContactHiroaki Azukizawa

Osaka University,Graduate School of Medicine Department of Dermatology

azukizaw@derma.med.osaka-u.ac.jp06-6879-3031

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026